Back

From drugs to devices and back again: chemical vagal nerve stimulation for the treatment of heart failure

Cardiovascular Research

27 July 2017
Organised by: Logo
Read full article
ESC Journals

Contributors

Crystal M. Ripplinger
Crystal M. Ripplinger

Author

University of California Davis , United States of America

You may be interested in
thumbnail
Congress Presentation
2 September 2019
thumbnail
Congress Session
Evolving treatment paradigms in heart failure: from SGLT2 inhibition to transthyretin stabilisation and beyond
20 May 2025
thumbnail
Congress Presentation
Innovation in pacing therapies: where technology meets physiology
1 September 2025
thumbnail
Congress Presentation
Heart and brain axis in obesity
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources